Literature DB >> 2986425

Effect of dopamine receptor stimulation on the inhibition of LH pulsatility by a met-enkephaline (FK 33-824).

E del Pozo, J Martin-Perez.   

Abstract

Plasma LH fluctuations reflect pulsatile hypothalamic GnRH activity. In order to investigate a possible interaction between opiate and dopaminergic pathways in the control of LH and PRL release, a met-enkephalin analogue (FK 33-824) was administered intravenously to female volunteers at a rate of 0.01 mg/kg/h for 4 h. LH pulses as recorded by plasma measurements every 20' were significantly (p less than 0.01) inhibited whereas PRL concentrations were increased. Pre-treatment with bromocriptine, 1.25 mg b.i.d. for 3 days, counteracted the stimulatory effect of FK 33-824 on PRL secretion but the inhibitory effect on LH episodic release was not modified by this dopamine agonist. Results indicate that opiate receptor stimulation selectively depresses hypothalamic GnRH activity and enhances PRL release from pituitary lactotrops. The GnRH lowering effect does not seem to be mediated by dopaminergic mechanisms which govern PRL secretion. Also transient, opioid-induced hyperprolactinemia is not causally related to the suppression of hypothalamic GnRH activity.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2986425     DOI: 10.1007/bf01406327

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  14 in total

1.  Effects of naloxone, morphine and methionine enkephalin on serum prolactin, luteinizing hormone, follicle stimulating hormone, thyroid stimulating hormone and growth hormone.

Authors:  J F Bruni; D Van Vugt; S Marshall; J Meites
Journal:  Life Sci       Date:  1977-08-01       Impact factor: 5.037

2.  Morphine inhibition of ovulation: reversal by naloxone.

Authors:  P M Packman; J A Rothchild
Journal:  Endocrinology       Date:  1976-07       Impact factor: 4.736

3.  Morphine decreases luteinizing hormone by an action on the hypothalamic-pituitary axis.

Authors:  T J Cicero; T M Badger; C E Wilcox; R D Bell; E R Meyer
Journal:  J Pharmacol Exp Ther       Date:  1977-12       Impact factor: 4.030

4.  Naloxone inhibition of stress-induced increase in prolactin secretion.

Authors:  D A Van Vugt; J F Bruni; J Meites
Journal:  Life Sci       Date:  1978-01       Impact factor: 5.037

5.  Effects of the synthetic enkephalin analogue FK 33-824 in man.

Authors:  B von Graffenried; E del Pozo; J Roubicek; E Krebs; W Poldinger; P Burmeister; L Kerp
Journal:  Nature       Date:  1978-04-20       Impact factor: 49.962

6.  Effects of morphine and naloxone on inhibition by ovarian hormones of pulsatile release of LH in ovariectomized rats.

Authors:  P W Sylvester; D A Van Vugt; C A Aylsworth; E A Hanson; J Meites
Journal:  Neuroendocrinology       Date:  1982-04       Impact factor: 4.914

7.  Hyperprolactinemic anovulatory syndrome.

Authors:  H G Bohnet; H G Dahlén; W Wuttke; H P Schneider
Journal:  J Clin Endocrinol Metab       Date:  1976-01       Impact factor: 5.958

8.  The role of endogenous opiates in LH secretion during the menstrual cycle.

Authors:  M E Quigley; S S Yen
Journal:  J Clin Endocrinol Metab       Date:  1980-07       Impact factor: 5.958

9.  A radioimmunoassay for human prolactin.

Authors:  P Hwang; H Guyda; H Friesen
Journal:  Proc Natl Acad Sci U S A       Date:  1971-08       Impact factor: 11.205

10.  Endocrine effect of a methionine-enkephalin derivative (FK 33-824) in man.

Authors:  E del Pozo; B von Graffenried; J Brownell; F Derrer; P Marbach
Journal:  Horm Res       Date:  1980
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.